Highlights Revolution Medicines, Inc.

Equities

RVMD

US76155X1000

Biotechnology & Medical Research

Real-time Estimate Cboe BZX Other stock markets 15:13:14 10/02/2026 GMT			5-day change	1st Jan Change
96.33 ^USD	-0.42%		+1.08%	+21.80%

01-29	Revolution Medicines Says First Patient Dosed in Solid Tumor Trial	MT
01-29	Revolution Medicines Doses First Patient in Clinical Trial Evaluating RMC-5127, a RAS(ON) G12V-Selective Inhibitor	CI

Highlights

01-29	Revolution Medicines Doses First Patient in Clinical Trial Evaluating RMC-5127, a RAS(ON) G12V-Selective Inhibitor	CI
01-26	Health Care Up Ahead of UnitedHealth Earnings -- Health Care Roundup	DJ
01-26	Sector Update: Health Care Stocks Advance Late Afternoon	MT
01-26	MSD Reportedly Ends Takeover Talks with Revolution Medicines	CI
01-26	Sector Update: Health Care Stocks Higher Monday Afternoon	MT
01-26	Global markets live: Nvidia, Boeing, Morgan Stanley, IonQ, LVMH…
01-26	Sector Update: Health Care Stocks Mixed Premarket Monday	MT
01-26	Traders Cautious Ahead of Busy Earnings Week, Fed Rate Decision, Driving Muted Premarket Action for US Equity Futures	MT
01-26	Planting Hedges Early
01-26	Sector Update: Health Care	MT
01-26	Exchange-Traded Funds Lower, Equity Futures Mixed Pre-Bell Monday as Corporate Earnings Continue	MT
01-26	Revolution Medicines Shares Slide Premarket After Merck Talks Cool	DJ
01-26	Deals of the day-Mergers and acquisitions	RE
01-26	Merck Ends Talks to Buy Revolutions Medicines	MT
01-26	PRESS DIGEST-Wall Street Journal - January 26	RE
01-25	Merck no longer in talks to buy Revolution Medicines - WSJ	RE
01-25	Merck no longer in talks to buy Revolution Medicines, WSJ reports	RE
01-20	Deals of the day-Mergers and acquisitions	RE
01-09	Health Care Up Amid Deal Speculation -- Health Care Roundup	DJ
01-09	Sector Update: Health Care Stocks Decline Late Afternoon	MT
01-09	Sector Update: Health Care Stocks Mixed Friday Afternoon	MT
01-09	Sector Update: Health Care	MT
01-09	Top Midday Stories: December Jobs Data Undershoots Expectations; Meta Signs Nuclear Deals	MT
01-09	Healthcare dealmakers head to San Francisco hoping for megamergers in 2026	RE
01-09	Merck reportedly consiering a major acquisition (Revolution Medicines)

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages MarketScreener Editorial Features MarketScreener Strategies Trading Ideas

Highlights Revolution Medicines, Inc.

Equities

RVMD

US76155X1000

Biotechnology & Medical Research

Highlights

Filters